These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2990494)
1. A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Safayhi H; Tiegs G; Wendel A Biochem Pharmacol; 1985 Aug; 34(15):2691-4. PubMed ID: 2990494 [TBL] [Abstract][Full Text] [Related]
2. Effects of ebselen on arachidonate metabolism by ocular and non-ocular tissues. Hurst JS; Paterson CA; Bhattacherjee P; Pierce WM Biochem Pharmacol; 1989 Oct; 38(19):3357-63. PubMed ID: 2510732 [TBL] [Abstract][Full Text] [Related]
3. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
4. Ebselen: a new approach to the inhibition of peroxide-dependent inflammation. Parnham MJ; Leyck S; Kuhl P; Schalkwijk J; van den Berg WB Int J Tissue React; 1987; 9(1):45-50. PubMed ID: 3036734 [TBL] [Abstract][Full Text] [Related]
5. A novel biologically active seleno-organic compound--III. Effects of PZ 51 (Ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Parnham MJ; Kindt S Biochem Pharmacol; 1984 Oct; 33(20):3247-50. PubMed ID: 6593071 [TBL] [Abstract][Full Text] [Related]
6. Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans-isomer. Kuhl P; Borbe HO; Fischer H; Römer A; Safayhi H Prostaglandins; 1986 Jun; 31(6):1029-48. PubMed ID: 3020614 [TBL] [Abstract][Full Text] [Related]
7. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils. Patrick RA; Peters PA; Issekutz AC Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742 [TBL] [Abstract][Full Text] [Related]
8. A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Müller A; Cadenas E; Graf P; Sies H Biochem Pharmacol; 1984 Oct; 33(20):3235-9. PubMed ID: 6487370 [TBL] [Abstract][Full Text] [Related]
9. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione. Schewe C; Schewe T; Wendel A Biochem Pharmacol; 1994 Jul; 48(1):65-74. PubMed ID: 8043032 [TBL] [Abstract][Full Text] [Related]
10. [Effect of seleno-organic compounds on leukotriene B4 biosynthesis]. Liu DP; Cheng GF; Bai JY; Guo ZR; Zhu XY Yao Xue Xue Bao; 1993; 28(6):472-6. PubMed ID: 8249607 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Ammon HP; Mack T; Singh GB; Safayhi H Planta Med; 1991 Jun; 57(3):203-7. PubMed ID: 1654575 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of leukotriene B4 formation by Ebselen: a novel approach to antiinflammatory therapy. Kuhl P; Borbe HO; Römer A; Fischer H; Parnham MJ Agents Actions; 1986 Jan; 17(3-4):366-7. PubMed ID: 3008531 [No Abstract] [Full Text] [Related]
13. The anti-inflammatory activity of Ebselen but not thiols in experimental alveolitis and bronchiolitis. Cotgreave IA; Johansson U; Westergren G; Moldéus PW; Brattsand R Agents Actions; 1988 Jul; 24(3-4):313-9. PubMed ID: 2459936 [TBL] [Abstract][Full Text] [Related]
14. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen. Leyck S; Parnham MJ Agents Actions; 1990 Jun; 30(3-4):426-31. PubMed ID: 2117337 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen. Ichikawa S; Omura K; Katayama T; Okamura N; Ohtsuka T; Ishibashi S; Masayasu H J Pharmacobiodyn; 1987 Oct; 10(10):595-7. PubMed ID: 2831335 [TBL] [Abstract][Full Text] [Related]
16. A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase. Wendel A; Fausel M; Safayhi H; Tiegs G; Otter R Biochem Pharmacol; 1984 Oct; 33(20):3241-5. PubMed ID: 6487371 [TBL] [Abstract][Full Text] [Related]
17. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione. Huwyler J; Bürgin M; Zeugin T; Gut J Mol Pharmacol; 1991 Mar; 39(3):314-23. PubMed ID: 1848655 [TBL] [Abstract][Full Text] [Related]
18. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Maiorino M; Roveri A; Coassin M; Ursini F Biochem Pharmacol; 1988 Jun; 37(11):2267-71. PubMed ID: 3377822 [TBL] [Abstract][Full Text] [Related]
19. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. Williams JD; Lee TH; Lewis RA; Austen F J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947 [TBL] [Abstract][Full Text] [Related]
20. Some aspects of cardiac antioxidant defence: Ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart. Hermenegildo C; Nies E; Monsalve E; Puertas FJ; Higueras V; Romero FJ Biochem Soc Trans; 1990 Dec; 18(6):1193-4. PubMed ID: 2088859 [No Abstract] [Full Text] [Related] [Next] [New Search]